Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classification

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Kojima, Kensuke ^a   April, Craig ^b   Canasto Chibuque, Claudia ^a   Chen, Xintong ^a   Deshmukh, Manjeet ^a   Venkatesh, Anu ^a   Tan, Poh Seng ^a   Kobayashi, Masahiro ^c   Kumada, Hiromitsu ^c   Fan, Jian Bing ^b   Hoshida, Yujin ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ILLUMINA INC   (United States)

^c TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; RNA; TRANSCRIPTOME; FIXATIVE; MESSENGER RNA;

ARCHIVED SECTIONED FORMALIN FIXED PARAFFIN EMBEDDED TISSUE; ARTICLE; CANCER PROGNOSIS; DISEASE CLASSIFICATION; EMBEDDING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PREDICTION; REPRODUCIBILITY; RETROSPECTIVE STUDY; RNA EXTRACTION; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; GENE EXPRESSION PROFILING; GENETICS; ISOLATION AND PURIFICATION; LIVER NEOPLASMS; METABOLISM; PROGNOSIS; TISSUE FIXATION;

CARCINOMA, HEPATOCELLULAR; FIXATIVES; FORMALDEHYDE; GENE EXPRESSION PROFILING; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; PARAFFIN EMBEDDING; PROGNOSIS; RNA, MESSENGER; TISSUE FIXATION; TRANSCRIPTOME;

EID: 84900450842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086961     Document Type: Article

References (32)

1. Koscielny S (2010) Why most gene expression signatures of tumors have not been useful in the clinic. Sci Transl Med 2: 14ps12.
2. Simon RM, Paik S, Hayes DF (2009) Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst 101: 1446-1452.
3. Fox CH, Johnson FB, Whiting J, Roller PP (1985) Formaldehyde fixation. J Histochem Cytochem 33: 845-853.
4. von Ahlfen S, Missel A, Bendrat K, Schlumpberger M (2007) Determinants of RNA quality from FFPE samples. PLoS ONE 2: e1261.
5. Rhee Y, Valentine MR, Termini J (1995) Oxidative base damage in RNA detected by reverse transcriptase. Nucleic Acids Res 23: 3275-3282.
6. April C, Klotzle B, Royce T, Wickham-Garcia E, Boyaniwsky T, et al. (2009) Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples. PLoS One 4: e8162.
7. Bibikova M, Talantov D, Chudin E, Yeakley JM, Chen J, et al. (2004) Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 165: 1799-1807. (Pubitemid 39435177)
8. Fan JB, Yeakley JM, Bibikova M, Chudin E, Wickham E, et al. (2004) A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res 14: 878-885. (Pubitemid 38660505)
9. Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, et al. (2013) Prognostic Gene-Expression Signature for Patients with Hepatitis C-Related Early-Stage Cirrhosis. Gastroenterology 144: 1024-1030.
10. Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, et al. (2013) Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 144: 829-840.
11. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, et al. (2012) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61: 847-854.
12. Waldron L, Ogino S, Hoshida Y, Shima K, McCart Reed AE, et al. (2012) Expression profiling of archival tumors for long-term health studies. Clin Cancer Res 18: 6136-6146.
13. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, et al. (2011) Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 140: 1501-1512 e1502.
14. Penney KL, Sinnott JA, Fall K, Pawitan Y, Hoshida Y, et al. (2011) mRNA Expression Signature of Gleason Grade Predicts Lethal Prostate Cancer. J Clin Oncol 29: 2391-2396.
15. Minguez B, Hoshida Y, Villanueva A, Toffanin S, Cabellos L, et al. (2011) Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol 55: 1325-1331.
16. Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, et al. (2010) Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics 3: 8.
17. Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, et al. (2009) Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69: 7385-7392.
18. Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, et al. (2008) Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst 100: 815-825. (Pubitemid 351809667)
19. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, et al. (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359: 1995-2004.
20. Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, et al. (2011) SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 470: 269-273.
21. Korbler T, Grskovic M, Dominis M, Antica M (2003) A simple method for RNA isolation from formalin-fixed and paraffin-embedded lymphatic tissues. Exp Mol Pathol 74: 336-340. (Pubitemid 36629233)
22. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, et al. (2002) A new nonlinear normalization method for reducing variability in DNA microarray experiments. Genome Biol 3: research0048.
23. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, et al. (2006) GenePattern 2.0. Nat Genet 38: 500-501.
24. Reis PP, Waldron L, Goswami RS, Xu W, Xuan Y, et al. (2011) mRNA transcript quantification in archival samples using multiplexed, color-coded probes. BMC Biotechnol 11: 46.
25. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, et al. (2008) Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26: 317-325. (Pubitemid 351355126)
26. Hoshida Y (2010) Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment. PLoS One 5: e15543.
27. Kan Z, Zheng H, Liu X, Li S, Barber TD, et al. (2013) Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res 23: 1422-1433.
28. Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, et al. (2012) Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer Res 18: 4997-5007.
29. Toffanin S, Hoshida Y, Lachenmayer A, Villanueva A, Cabellos L, et al. (2011) MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a. Gastroenterology 140: 1618-1628 e1616.
30. Nault JC, De Reynies A, Villanueva A, Calderaro J, Rebouissou S, et al. (2013) A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. Gastroenterology 145: 176-187.
31. Northcott PA, Shih DJ, Remke M, Cho YJ, Kool M, et al. (2012) Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol 123: 615-626.
32. Tanabe KK, Hoshida Y (2013) Prognostic Gene Signatures for Hepatocellular Carcinoma: What Are We Measuring? Ann Surg Oncol 20: 3707-3708. Kidney Diseases